Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects have?
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects has 41 citations in the OpenAlex counts ScholarIQ stores.
When was Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects published?
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects has 2018 year in the ScholarIQ index.
What is the open-access status of Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects?
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects has closed oa status in the ScholarIQ index.
What is the DOI of Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects?
The DOI for Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects is on the source record.
What is the PMID of Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects?
The PMID for Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects is on the source record.
What is the OpenAlex record for Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects?
The OpenAlex for Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects is on the source record.